Levonorgestrel-releasing intrauterine system - Bayer
Alternative Names: Kyleena; LNG-IUS 12Latest Information Update: 02 Sep 2022
Price :
$50 *
At a glance
- Originator Bayer
- Class Hormonal contraceptives; Hormonal replacements; Norpregnanes; Progesterone congeners; Small molecules
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Pregnancy
Most Recent Events
- 05 Aug 2022 Bayer completes a phase III trial in Pregnancy (Prevention) in Russia (Intrauterine) (NCT03074045)
- 22 Feb 2022 No development reported - Phase-III for Pregnancy (Prevention) in Mexico, Argentina, Chile, Finland, France, Hungary, Netherlands, Sweden (Intrauterine)
- 04 Feb 2019 Chemical structure information added